Who gets skin cancer: individual risk factors
10.1007/978-94-017-0511-0_2
Crossref book-chapter
Springer Netherlands
Cancer Prevention — Cancer Causes (297)
Bibliography

Elwood, J. M. (2004). Who gets skin cancer: individual risk factors. Prevention of Skin Cancer, 3–20.

Authors 1
  1. J. Mark Elwood (first)
References 95 Referenced 12
  1. Staples M, Marks R, Giles G (1998) Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–1995: are primary prevention programs starting to have an effect? Int J Cancer 78: 144–148. (10.1002/(SICI)1097-0215(19981005)78:2<144::AID-IJC3>3.0.CO;2-Z) / Int J Cancer by M Staples (1998)
  2. Koh HK, Lew RA, Geller AC et al. (2002) Skin cancer: prevention and control. In: Greenwald P, Kramer BS, Weed DL, eds. Cancer Prevention and Control. New York: Marcel Dekker Inc., pp. 611–640. / Cancer Prevention and Control by HK Koh (2002)
  3. American Academy of Dermatology Committee on Guidelines of Care, Drake LA, Ceilley RI et al. (1992) Guidelines of care for basal cell carcinoma. J Am Acad Dermatol 26: 117–120. (10.1016/S0190-9622(08)80524-5) / J Am Acad Dermatol by American Academy of Dermatology Committee on Guidelines of Care (1992)
  4. American Academy of Dermatology Committee on Guidelines of Care (1993) Guidelines of care for cutaneous squamous cell carcinoma. J Am Acad Dermatol 28: 628–631. (10.1016/S0190-9622(08)81782-3) / J Am Acad Dermatol by American Academy of Dermatology Committee on Guidelines of Care (1993)
  5. Marks R, Gebauer K, Shumack S et al. (2001) Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol. 44: 807–813. (10.1067/mjd.2001.113689) / J Am Acad Dermatol by R Marks (2001)
  6. Stockfleth E, Meyer T, Benninghoff B et al. (2001) Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 144: 1050–1053. (10.1046/j.1365-2133.2001.04197.x) / Br J Dermatol by E Stockfleth (2001)
  7. Soong S, Weiss HL (1998) Predicting outcome in patients with localized melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong S, eds. Cutaneous Melanoma. St. Louis, Missouri: Quality Medical Publishing Inc., pp. 51–79. / Cutaneous Melanoma. St by S Soong (1998)
  8. Balch CM, Buzaid AC, Atkins MB et al. (2000) A new American joint committee on cancer staging system for cutaneous melanoma. Cancer 88: 1484–1491. (10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D) / Cancer by CM Balch (2000)
  9. Ahmed I, Berth-Jones J (2000) Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol 143: 843–845. (10.1046/j.1365-2133.2000.03787.x) / Br J Dermatol by I Ahmed (2000)
  10. Wassberg C, Thorn M, Yuen J et al. (1996) Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 73: 255–259. (10.1038/bjc.1996.45) / Br J Cancer by C Wassberg (1996)
  11. Giles G, Staples M, McCredie M et al. (1995) Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res 5: 433–438. (10.1097/00008390-199512000-00007) / Melanoma Res by G Giles (1995)
  12. Brash DE, Bale AE (2001) Cancer of the skin. In: De Vita VT, Jr., Hellman S, and Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelpia: Lippincott Williams and Wilkins, pp. 1971–1975. / Cancer: principles and practice of oncology by DE Brash (2001)
  13. Brash DE, Ponten J (1998) Skin precancer. Cancer Surv 32: 69–113. / Cancer Surv by DE Brash (1998)
  14. Marks R, Foley P, Goodman G et al. (1986) Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 115: 649–655. (10.1111/j.1365-2133.1986.tb06644.x) / Br J Dermatol by R Marks (1986)
  15. Dodson JM, DeSpain J, Hewett JE et al. (199 1) Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 127: 1029–1031. (10.1001/archderm.1991.01680060103013) / Arch Dermatol by JM Dodson (199)
  16. Skender-Kalnenas TM, English DR, Heenan PJ (1995) Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 33: 780–785. (10.1016/0190-9622(95)90294-5) / J Am Acad Dermatol by TM Skender-Kalnenas (1995)
  17. Armstrong BK, English DR (1988) The epidemiology of acquired melanocytic naevi and their relationship to malignant melanoma. In: Elwood JM ed. Melanoma and Naevi, Pigment Cell, Vol. 9. Basle: Karger, pp. 27–47. / Melanoma and Naevi, Pigment Cell, Vol by BK Armstrong (1988)
  18. Barnhill RL, Mihm CM Jr (2002) Histopathology and precursor lesions. In: Balch CM, Houghton AN, Sober AJ, Soong S, eds. Cutaneous Melanoma. St. Louis, Missouri: Quality Medical Publishing Inc., pp. 103–133 / Cutaneous Melanoma. St by RL Barnhill (2002)
  19. Grob JJ, Andrac L, Romano MH et al. (1988) Dysplastic naevus in non-familial melanoma. A clinicopathological study of 101 cases. Br J Dermatol 118: 745–752. (10.1111/j.1365-2133.1988.tb02591.x) / Br J Dermatol by JJ Grob (1988)
  20. Carli P, Biggeri A, Nardini P et al. (1998) Sun exposure and large numbers of common and atypical melanocytic naevi: an analytical study in a southern European population. Br J Dermatol 138: 422–425. (10.1046/j.1365-2133.1998.02118.x) / Br J Dermatol by P Carli (1998)
  21. Garbe C, Buttner P, Weiss J et al. (1994) Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicentre case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102: 695–699. (10.1111/1523-1747.ep12374280) / J Invest Dermatol by C Garbe (1994)
  22. Schneider JS, Moore DH, Sagebiel RW (1994) Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi. Arch Dermatol 130: 1002–1007. (10.1001/archderm.1994.01690080068009) / Arch Dermatol by JS Schneider (1994)
  23. Green A, Swerdlow AJ (1989) Epidemiology of melanocytic nevi. Epidemiol Rev 11: 204–221. (10.1093/oxfordjournals.epirev.a036037) / Epidemiol Rev by A Green (1989)
  24. Harrison SL, MacKie RM, MacLennan R (2000) Development of melanocytic nevi in the first three years of life. J Natl Cancer Inst 92: 1436–1438. (10.1093/jnci/92.17.1436) / J Natl Cancer Inst by SL Harrison (2000)
  25. Kelly JW, Rivers JK, MacLennan R et al. (1994) Sunlight: A major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol. 30: 40–48. (10.1016/S0190-9622(94)70005-2) / J Am Acad Dermatol by JW Kelly (1994)
  26. Autier P, Boniol M, Severi G et al. (2001) The body site distribution of melanocytic naevi in 6–7 year old European children. Melanoma Res 11: 123–131. (10.1097/00008390-200104000-00006) / Melanoma Res by P Autier (2001)
  27. Harrison SL, Buettner PG, MacLennan R (1999) Body-site distribution of melanocytic nevi in young Australian children. Arch Dermatol 135: 47–52. (10.1001/archderm.135.1.47) / Arch Dermatol by SL Harrison (1999)
  28. Whiteman DC, Valery P, McWhirter W et al. (1997) Risk factors for childhood melanoma in Queensland, Australia. Int. J Cancer 70: 26–31. (10.1002/(SICI)1097-0215(19970106)70:1<26::AID-IJC4>3.0.CO;2-8) / Int. J Cancer by DC Whiteman (1997)
  29. Green A (1992) A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Control 3: 513–516. (10.1007/BF00052747) / Cancer Causes Control by A Green (1992)
  30. Lock-Andersen J, Drzewiecki KT, Wulf HC (1999) Naevi as a risk factor for basal cell carcinoma in Caucasians: a Danish case-control study. Acta Derm Venereol 79: 314–319. (10.1080/000155599750010742) / Acta Derm Venereol by J Lock-Andersen (1999)
  31. Bliss JM, Ford D, Swerdlow AJ et al. (1995) Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 62: 367–376. (10.1002/ijc.2910620402) / Int J Cancer by JM Bliss (1995)
  32. Naldi L, Lorenzo IG, Parazzini F et al. (2000) Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer 88: 2703–2710. (10.1002/1097-0142(20000615)88:12<2703::AID-CNCR8>3.0.CO;2-Q) / Cancer by L Naldi (2000)
  33. Tabenkin H, Tamir A, Sperber AD et al. (1999) A case-control study of malignant melanoma in Israeli kibbutzim. Isr Med Assoc J 1: 154–157. / Isr Med Assoc J by H Tabenkin (1999)
  34. Stern RS, Momtaz K (1984) Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy. Arch Dermatol 120: 869–873. (10.1001/archderm.1984.01650430055010) / Arch Dermatol by RS Stern (1984)
  35. Weinstock MA (1992) Assessment of sun sensitivity by questionnaire: validity of items and formulation of a prediction rule. J Clin Epidemiol 45: 547–552. (10.1016/0895-4356(92)90104-U) / J Clin Epidemiol by MA Weinstock (1992)
  36. Green A, Battistutta D (1990) Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 46: 356–361. (10.1002/ijc.2910460303) / Int J Cancer by A Green (1990)
  37. van Dam RM, Huang Z, Rimm EB et al. (1999) Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol 150: 459–468. (10.1093/oxfordjournals.aje.a010034) / Am J Epidemiol by RM Dam van (1999)
  38. Greene MH (1999) The genetics of hereditary melanoma and nevi. 1998 update. Cancer 86: 2464–2477. (10.1002/(SICI)1097-0142(19991201)86:11+<2464::AID-CNCR3>3.0.CO;2-F) / Cancer by MH Greene (1999)
  39. Hayward N (2000) New developments in melanoma genetics. Curr Oncol Rep 2: 300–306. (10.1007/s11912-000-0022-z) / Curr Oncol Rep by N Hayward (2000)
  40. Ford D, Bliss JM, Swerdlow AJ et al. (1995) Risk of cutaneous melanoma associated with a family history of the disease. Int. J Cancer 62: 377–381. (10.1002/ijc.2910620403) / Int. J Cancer by D Ford (1995)
  41. Greene MH, Clark WH Jr., Tucker MA et al. (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102: 458–465. (10.7326/0003-4819-102-4-458) / Ann Intern Med by MH Greene (1985)
  42. Aitken JF, Youl P, Green A et al. (1996) Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 6: 313–317. (10.1097/00008390-199608000-00006) / Melanoma Res by JF Aitken (1996)
  43. Aitken JF, Green AC, MacLennan R et al. (1996) The Queensland Familial Melanoma Project: study design and characteristics of participants. Melanoma Res 6: 155–165. (10.1097/00008390-199604000-00011) / Melanoma Res by JF Aitken (1996)
  44. Weinstock MA, Brodsky GL (1998) Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study. J Clin Epidemiol 51: 1299–1303. (10.1016/S0895-4356(98)00070-5) / J Clin Epidemiol by MA Weinstock (1998)
  45. Kraemer KH, Lee MM, Andrews AD et al. (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130: 1018–1021. (10.1001/archderm.1994.01690080084012) / Arch Dermatol by KH Kraemer (1994)
  46. Lambe M, Thörn M, Sparén P et al. (1996) Malignant melanoma: reduced risk associated with early childbearing and multiparity. Melanoma Res 6: 147–153. (10.1097/00008390-199604000-00010) / Melanoma Res by M Lambe (1996)
  47. Gallagher RP, Elwood JM, Hill GB et al. (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 52: 891–907. / Br J Cancer by RP Gallagher (1985)
  48. Armstrong BK, English DR (1996) Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni, JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, pp. 1282–1312. / Cancer epidemiology and prevention by BK Armstrong (1996)
  49. Palmer JR, Rosenberg L, Strom BL et al. (1992) Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 3: 547–554. (10.1007/BF00052752) / Cancer Causes Control by JR Palmer (1992)
  50. Feskanich D, Hunter DJ, Willett WC et al. (1999) Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 81: 918–923. (10.1038/sj.bjc.6690787) / Br J Cancer by D Feskanich (1999)
  51. Veierod MB, Thelle DS, Laake P (1997) Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int. J Cancer 71: 600–604. (10.1002/(SICI)1097-0215(19970516)71:4<600::AID-IJC15>3.0.CO;2-F) / Int. J Cancer by MB Veierod (1997)
  52. Kirkpatrick CS, White E, Lee JAH (1994) Case-control study of malignant melanoma in Washington State. 2. Diet, alcohol, and obesity. Am J Epidemiol 139: 869–880. (10.1093/oxfordjournals.aje.a117093) / Am J Epidemiol by CS Kirkpatrick (1994)
  53. Ros-Bullón MR, Sânchez-Pedreiïo P, Martínez-Liarte JH (1998) Serum zinc levels are increased in melanoma patients. Melanoma Res 8: 273–277. (10.1097/00008390-199806000-00011) / Melanoma Res by MR Ros-Bullón (1998)
  54. Weinstock MA, Stampfer MJ, Lew RA et al. (1992) Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J Invest Dermatol 98: 809–811. (10.1111/1523-1747.ep12499962) / J Invest Dermatol by MA Weinstock (1992)
  55. Thune I, Olsen A, Albrektsen G et al. (1993) Cutaneous malignant melanoma: association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer 55: 555–561. (10.1002/ijc.2910550406) / Int J Cancer by I Thune (1993)
  56. Smith MA, Fine JA, Barnhill RL et al. (1998) Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol 27: 751–757. (10.1093/ije/27.5.751) / Int J Epidemiol by MA Smith (1998)
  57. Hakim IA, Harris RB, Ritenbaugh C (2000) Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin. Nutr Cancer 37: 161–168. (10.1207/S15327914NC372_7) / Nutr Cancer by IA Hakim (2000)
  58. Greenberg ER, Baron JA, Stukel TA et al. (1990) A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 323: 789–795. (10.1056/NEJM199009203231204) / N Engl J Med by ER Greenberg (1990)
  59. Tangrea JA, Edwards BK, Taylor PR et al. (1992) Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst 84: 328–332. (10.1093/jnci/84.5.328) / J Natl Cancer Inst by JA Tangrea (1992)
  60. Clark LC, Combs GF, Jr., Turnbull BW et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957–1963. (10.1001/jama.1996.03540240035027) / JAMA by LC Clark (1996)
  61. De Hertog SA, Wensveen CA, Bastiaens MT et al. (200 1) Relation between smoking and skin cancer. J Clin Oncol 19: 231–238. (10.1200/JCO.2001.19.1.231) / J Clin Oncol by SA Hertog (200)
  62. Grodstein F, Speizer FE, Hunter DJ (1995) A prospective study of incident squamous cell carcinoma of the skin in the Nurses’ Health Study. J Natl Cancer Inst 87: 1061–1066. (10.1093/jnci/87.14.1061) / J Natl Cancer Inst by F Grodstein (1995)
  63. Hunter DJ, Colditz GA, Stampfer MJ et al. (1990) Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1: 13–23. (10.1016/1047-2797(90)90015-K) / Ann Epidemiol by DJ Hunter (1990)
  64. Harris RE, Beebe-Donk J, Namboodiri KK (2001) Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women. Oncol Rep 8: 655–657. / Oncol Rep by RE Harris (2001)
  65. Halpern SM, Anstey AV, Dawe RS et al. (2000) Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol 142: 22–31. (10.1046/j.1365-2133.2000.03237.x) / Br J Dermatol by SM Halpern (2000)
  66. Stern RS, Liebman EJ, Väkevä L et al. (1998) Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. J Natl Cancer Inst 90: 1278–1284. (10.1093/jnci/90.17.1278) / J Natl Cancer Inst by RS Stern (1998)
  67. Lindelof B, Sigurgeirsson B, Tegner E et al. (1999) PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 141: 108–112. (10.1046/j.1365-2133.1999.02928.x) / Br J Dermatol by B Lindelof (1999)
  68. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E et al. (1999) Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 141: 497–501. (10.1046/j.1365-2133.1999.03044.x) / Br J Dermatol by A Hannuksela-Svahn (1999)
  69. Stern RS (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad. Dermatol 44: 755–761. (10.1067/mjd.2001.114576) / J Am Acad. Dermatol by RS Stern (2001)
  70. Kolmel KF, Pfahlberg A, Mastrangelo G et al. (1999) Infections and melanoma risk: results of a multicentre EORTC case-control study. Melanoma Res 9: 511–519. (10.1097/00008390-199910000-00011) / Melanoma Res by KF Kolmel (1999)
  71. Jablonska S (1991) Epidermodysplasia verruciformis. In: Friedman RJ, Rigel DS, Kopf AW, Harris MN, Baker D, eds. Cancer of the skin. Philadelphia: WB Saunders Co., pp. 101–113. / Cancer of the skin by S Jablonska (1991)
  72. Shamanin V, zur Hausen H, Lavergne D et al. (1996) Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 88: 802–811. (10.1093/jnci/88.12.802) / J Natl Cancer Inst by V Shamanin (1996)
  73. Burk RD, Kadish AS (1996) Treasure hunt for human papillomavirus in nonmelanoma skin cancers. J Natl Cancer Inst 88: 781–782. (10.1093/jnci/88.12.781) / J Natl Cancer Inst by RD Burk (1996)
  74. Kiviat NB (1999) Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Semin Cancer Biol 9: 397–403. (10.1006/scbi.1999.0143) / Semin Cancer Biol by NB Kiviat (1999)
  75. Dreau D, Culberson C, Wyatt S et al. (2000) Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression. Ann Surg 231: 664–671. (10.1097/00000658-200005000-00006) / Ann Surg by D Dreau (2000)
  76. Jensen P, Hansen S, Moller B et al. (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 40: 177–186. (10.1016/S0190-9622(99)70185-4) / J Am Acad Dermatol by P Jensen (1999)
  77. Marcil I, Stern RS (2000) Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 136: 1524–1530. (10.1001/archderm.136.12.1524) / Arch Dermatol by I Marcil (2000)
  78. Smith CH, McGregor JM, Barker JNWN et al. (1993) Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol. 28: 51–55. (10.1016/0190-9622(93)70008-H) / J Am Acad Dermatol by CH Smith (1993)
  79. Askling J, Grunewald J, Eklund A et al. (1999) Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 160: 1668–1672. (10.1164/ajrccm.160.5.9904045) / Am J Respir Crit Care Med by J Askling (1999)
  80. Adami J, Frisch M, Yuen J et al. (1995) Evidence of an association between non-Hodgkin’s lymphoma and skin cancer. BMJ 310: 1491–1495. (10.1136/bmj.310.6993.1491) / BMJ by J Adami (1995)
  81. Frisch M, Melbye M (1995) New primary cancers after squamous cell skin cancer. Am J Epidemiol 141: 916–922. (10.1093/oxfordjournals.aje.a117358) / Am J Epidemiol by M Frisch (1995)
  82. Kahn HS, Tatham LM, Patel AV et al. (1998) Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 280: 910–912. (10.1001/jama.280.10.910) / JAMA by HS Kahn (1998)
  83. Scotto J, Fears TR, Kraemer KH et al. (1996) Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, pp. 1313–1330. / Cancer epidemiology and prevention by J Scotto (1996)
  84. Shore RE (2001) Radiation-induced skin cancer in humans. Med Pediatr Oncol 36: 549–554. (10.1002/mpo.1128) / Med Pediatr Oncol by RE Shore (2001)
  85. Karagas MR, McDonald JA, Greenberg ER et al. (1996) Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J Natl Cancer Inst 88: 1848–1853. (10.1093/jnci/88.24.1848) / J Natl Cancer Inst by MR Karagas (1996)
  86. Hiatt RA, Krieger N, Sagebiel RW et al. (1993) Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Livermore National Laboratory. Epidemiology 4: 43–47. (10.1097/00001648-199301000-00009) / Epidemiology by RA Hiatt (1993)
  87. Austin DF, Reynolds P (1997) Investigation of an excess of melanoma among employees of the Lawrence Livermore National Laboratory. Am J Epidemiol 145: 524–531. (10.1093/oxfordjournals.aje.a009140) / Am J Epidemiol by DF Austin (1997)
  88. Acquavella JF, Wilkinson GS, Tietjen GL et al. (1983) A melanoma case-control study at the Los Alamos National Laboratory. Health Phys 45: 587–592. (10.1097/00004032-198309000-00001) / Health Phys by JF Acquavella (1983)
  89. Green A, Battistutta D, Hart V et al. (1996) Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. Am J Epidemiol 144: 1034–1040. (10.1093/oxfordjournals.aje.a008875) / Am J Epidemiol by A Green (1996)
  90. Hakansson N, Floderus B, Gustavsson P et al. (2001) Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 12: 552–557. (10.1097/00001648-200109000-00015) / Epidemiology by N Hakansson (2001)
  91. Khuder SA (1999) Etiologic clues to lip cancer from epidemiologic studies on farmers. Scand J Work Environ Health 25: 125–130. (10.5271/sjweh.414) / Scand J Work Environ Health by SA Khuder (1999)
  92. Pott P (1775) Chirurgical observations relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures, and the mortification of the hands and feet. London: Hawse Clark and Collins. / Chirurgical observations relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures, and the mortification of the hands and feet by P Pott (1775)
  93. Shannon RL, Strayer DS (1989) Arsenic induced skin toxicity. Hum Toxicol 8: 99–104. (10.1177/096032718900800203) / Hum Toxicol by RL Shannon (1989)
  94. Hsueh S, Cheng GS, Wu MM et al. (1995) Multiple risk factors associated with arsenic-induced skin cancer: Effects of chronic liver disease and malnutritional status. Br J Cancer 71: 109–114. (10.1038/bjc.1995.22) / Br J Cancer by S Hsueh (1995)
  95. Karagas MR, Stukel TA, Morris JS et al. (2001) Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 153: 559–565. (10.1093/aje/153.6.559) / Am J Epidemiol by MR Karagas (2001)
Dates
Type When
Created 12 years, 7 months ago (Jan. 21, 2013, 1:43 p.m.)
Deposited 4 years, 8 months ago (Dec. 7, 2020, 9:06 a.m.)
Indexed 4 months, 4 weeks ago (April 6, 2025, 11:10 a.m.)
Issued 21 years, 8 months ago (Jan. 1, 2004)
Published 21 years, 8 months ago (Jan. 1, 2004)
Published Print 21 years, 8 months ago (Jan. 1, 2004)
Funders 0

None

@inbook{Elwood_2004, title={Who gets skin cancer: individual risk factors}, ISBN={9789401705110}, ISSN={1568-2595}, url={http://dx.doi.org/10.1007/978-94-017-0511-0_2}, DOI={10.1007/978-94-017-0511-0_2}, booktitle={Prevention of Skin Cancer}, publisher={Springer Netherlands}, author={Elwood, J. Mark}, year={2004}, pages={3–20} }